{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:08:25Z","timestamp":1790129305105,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ejca.2015.04.023","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T08:50:08Z","timestamp":1432975808000},"page":"1603-1610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives"],"prefix":"10.1016","volume":"51","author":[{"given":"Sabrina","family":"Croce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6053","key":"10.1016\/j.ejca.2015.04.023_b0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.ejca.2015.04.023_b0010","first-page":"174","article-title":"The genomic structure and developmental expression patterns of the human OPA-containing gene (HOPA)","volume":"105","author":"Philibert","year":"1999","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.023_b0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tibs.2010.02.004","article-title":"The human Mediator complex: a versatile, genome-wide regulator of transcription","volume":"35","author":"Taatjes","year":"2010","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"10.1016\/j.ejca.2015.04.023_b0020","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0092-8674(93)90362-T","article-title":"A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast","volume":"73","author":"Thompson","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(94)90221-6","article-title":"A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II","volume":"77","author":"Kim","year":"1994","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.ejca.2015.04.023_b0030","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1073\/pnas.93.16.8329","article-title":"Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex","volume":"93","author":"Fondell","year":"1996","journal-title":"Proc Natl. Acad Sci USA"},{"issue":"6718","key":"10.1016\/j.ejca.2015.04.023_b0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/17141","article-title":"The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1","volume":"397","author":"Ryu","year":"1999","journal-title":"Nature"},{"issue":"5404","key":"10.1016\/j.ejca.2015.04.023_b0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.283.5404.985","article-title":"Conserved structures of mediator and RNA polymerase II holoenzyme","volume":"283","author":"Asturias","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.str.2009.01.016","article-title":"Mediator structural conservation and implications for the regulation mechanism","volume":"17","author":"Cai","year":"2009","journal-title":"Structure"},{"issue":"45","key":"10.1016\/j.ejca.2015.04.023_b0050","doi-asserted-by":"crossref","first-page":"42003","DOI":"10.1074\/jbc.M105961200","article-title":"The structural and functional organization of the yeast mediator complex","volume":"276","author":"Kang","year":"2001","journal-title":"J Biol Chem"},{"issue":"5557","key":"10.1016\/j.ejca.2015.04.023_b0055","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1126\/science.1065249","article-title":"Structure, function, and activator-induced conformations of the CRSP coactivator","volume":"295","author":"Taatjes","year":"2002","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ejca.2015.04.023_b0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/embo-reports\/kve186","article-title":"Novel critical role of a human Mediator complex for basal RNA polymerase II transcription","volume":"2","author":"Mittler","year":"2001","journal-title":"EMBO Rep"},{"issue":"6800","key":"10.1016\/j.ejca.2015.04.023_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35024111","article-title":"TFIIH is negatively regulated by cdk8-containing mediator complexes","volume":"407","author":"Akoulitchev","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1101\/gad.1767009","article-title":"The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function","volume":"23","author":"Knuesel","year":"2009","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molcel.2005.06.033","article-title":"Mediator expression profiling epistasis reveals a signal transduction pathway with antagonistic submodules and highly specific downstream targets","volume":"19","author":"van de Peppel","year":"2005","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.023_b0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nsmb.1752","article-title":"CDK8 is a positive regulator of transcriptional elongation within the serum response network","volume":"17","author":"Donner","year":"2010","journal-title":"Nat Struct Mol Biol"},{"issue":"7212","key":"10.1016\/j.ejca.2015.04.023_b0085","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"},{"issue":"7212","key":"10.1016\/j.ejca.2015.04.023_b0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature07310","article-title":"E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8","volume":"455","author":"Morris","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejca.2015.04.023_b0095","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1101\/gad.987602","article-title":"Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation","volume":"16","author":"Naar","year":"2002","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molcel.2005.05.015","article-title":"MED1\/TRAP220 exists predominantly in a TRAP\/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription","volume":"19","author":"Zhang","year":"2005","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.023_b0105","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/MCB.25.6.2117-2129.2005","article-title":"Structural and functional characterization of PC2 and RNA polymerase II-associated subpopulations of metazoan Mediator","volume":"25","author":"Malik","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.023_b0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molcel.2008.05.023","article-title":"Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation","volume":"31","author":"Ding","year":"2008","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.023_b0115","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MCB.00993-08","article-title":"The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator","volume":"29","author":"Knuesel","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"51","key":"10.1016\/j.ejca.2015.04.023_b0120","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1073\/pnas.0509457102","article-title":"The zebrafish kohtalo\/trap230 gene is required for the development of the brain, neural crest, and pronephric kidney","volume":"102","author":"Hong","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ydbio.2006.04.437","article-title":"Zebrafish Trap230\/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development","volume":"296","author":"Rau","year":"2006","journal-title":"Dev Biol"},{"issue":"46","key":"10.1016\/j.ejca.2015.04.023_b0130","doi-asserted-by":"crossref","first-page":"17284","DOI":"10.1073\/pnas.0605414103","article-title":"A subunit of the mediator complex regulates vertebrate neuronal development","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.ejca.2015.04.023_b0135","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1101\/gad.814700","article-title":"Elegans mediator protein confers regulatory selectivity on lineage-specific expression of a transcription factor gene","volume":"14","author":"Zhang","year":"2000","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.mp.4000442","article-title":"Association of an X-chromosome dodecamer insertional variant allele with mental retardation","volume":"3","author":"Philibert","year":"1998","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng1992","article-title":"A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome","volume":"39","author":"Risheg","year":"2007","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.023_b0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.fertnstert.2014.06.040","article-title":"MED12 mutation frequency in unselected sporadic uterine leiomyomas","volume":"102","author":"Heinonen","year":"2014","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ejca.2015.04.023_b0160","doi-asserted-by":"crossref","first-page":"966","DOI":"10.18632\/oncotarget.370","article-title":"MED12 exon 2 mutations are common in uterine leiomyomas from South African patients","volume":"2","author":"Makinen","year":"2011","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.023_b0165","doi-asserted-by":"crossref","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","article-title":"Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas","volume":"7","author":"McGuire","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejca.2015.04.023_b0170","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.27424","article-title":"MED12 mutations in uterine fibroids\u2013their relationship to cytogenetic subgroups","volume":"131","author":"Markowski","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejca.2015.04.023_b0180","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/hmg\/dds051","article-title":"Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity","volume":"21","author":"Hodge","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.ejca.2015.04.023_b0185","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/humu.22612","article-title":"Mutations in exon 1 highlight the role of MED12 in uterine leiomyomas","volume":"35","author":"Kampjarvi","year":"2014","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/molehr\/4.1.83","article-title":"Cytogenetic abnormalities in uterine myomas are associated with myoma size","volume":"4","author":"Rein","year":"1998","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0195","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijc.28410","article-title":"Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas","volume":"134","author":"Makinen","year":"2014","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.023_b0200","doi-asserted-by":"crossref","first-page":"e40015","DOI":"10.1371\/journal.pone.0040015","article-title":"MED12 alterations in both human benign and malignant uterine soft tissue tumors","volume":"7","author":"Perot","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/his.12039","article-title":"Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours","volume":"62","author":"Matsubara","year":"2013","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.ejca.2015.04.023_b0210","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ejhg.2013.33","article-title":"MED12 exon 2 mutations in histopathological uterine leiomyoma variants","volume":"21","author":"Makinen","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.023_b0215","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.023_b0220","doi-asserted-by":"crossref","first-page":"E1044","DOI":"10.1002\/ijc.27610","article-title":"Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors","volume":"131","author":"Je","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1755-8166-6-23","article-title":"Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non-B DNA structures and hypermutability","volume":"6","author":"Markowski","year":"2013","journal-title":"Mol Cytogenet"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.023_b0230","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2014.03.047","article-title":"Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity","volume":"7","author":"Turunen","year":"2014","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.ejca.2015.04.023_b0235","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer","volume":"107","author":"Kampjarvi","year":"2012","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.023_b0240","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.humpath.2013.01.006","article-title":"Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity","volume":"44","author":"de Graaff","year":"2013","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.ejca.2015.04.023_b0245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/gcc.22029","article-title":"MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors","volume":"52","author":"Markowski","year":"2013","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2015.04.023_b0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2013.08.005","article-title":"MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors","volume":"45","author":"Schwetye","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2015.04.023_b0255","series-title":"WHO classification of tumours of female reproductive organs","first-page":"135","article-title":"Mesenchymal tumours. Smooth muscle tumour of uncertain malignant potential","author":"Oliva","year":"2014"},{"issue":"4","key":"10.1016\/j.ejca.2015.04.023_b0260","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/PAT.0b013e328360bf97","article-title":"Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent\/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata)","volume":"45","author":"Rieker","year":"2013","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.ejca.2015.04.023_b0265","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/path.4216","article-title":"Re: Stoehr et al. lack of evidence for frequent MED12 p. L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453\u2013456","volume":"231","author":"Barbieri","year":"2013","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ejca.2015.04.023_b0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ejca.2015.04.023_b0275","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ng.3037","article-title":"Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma","volume":"46","author":"Lim","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ejca.2015.04.023_b0280","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/bjc.2014.138","article-title":"Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas","volume":"110","author":"Makinen","year":"2014","journal-title":"Br J Cancer"},{"issue":"20","key":"10.1016\/j.ejca.2015.04.023_b0285","doi-asserted-by":"crossref","first-page":"14066","DOI":"10.1074\/jbc.M602696200","article-title":"Mediator is a transducer of Wnt\/beta-catenin signaling","volume":"281","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/j.ejca.2015.04.023_b0290","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1242\/dev.053660","article-title":"Med12 is essential for early mouse development and for canonical Wnt and Wnt\/PCP signaling","volume":"137","author":"Rocha","year":"2010","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.ejca.2015.04.023_b0295","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.cell.2012.10.035","article-title":"MED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signaling","volume":"151","author":"Huang","year":"2012","journal-title":"Cell"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915003858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T03:04:13Z","timestamp":1537585453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915003858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0959804915003858"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}